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1. Introduction 
Biochemical and electron microscopic evidence 
has shown that Escherichia coli RNA polymerase 
holoenzyme forms in vitro, in the absence of nucleo- 
side triphosphates, a stable and specific complex with 
bacteriophage T7 DNA in the early promoter region 
of the chromosome [ 1,2]. Neither the stability nor 
the specificity of this complex is altered by inactiva- 
tion of the RNA polymerase by the antibiotic 
rifampicin [2,3]. In work described in this letter T7 
DNA was first complexed with rifampicin-inactivated 
E. coli wild type RNA polymerase and was then used 
as template for an in vitro transcription assay. RNA 
synthesis in the presence of rifampicin was catalysed 
by E. coli rifampicin resistant RNA polymerase or by 
bacteriophage T7 RNA polymerase. The results 
show that rifampicin-inactivated E. coli RNA polymer- 
ase inhibits the activity of E. coZi rifampicin resistant 
enzyme but does not affect the activity of bacterio- 
phage T7 RNA polymerase. The mechanism of this 
inhibition is discussed along with its relation to the 
mechanism of dominance of rifampicin sensitivity 
over rifampicin resistance observed in bacteria hetero- 
zygous for the rifampicin alleles [4-71. 
2. Materials and methods 
E. coli B wild type (rifampicin sensitive) RNA 
polymerase holoenzyme was prepared according to 
Burgess [8] or Chamberlin and Berg [9]. E. coli 
rifampicin resistant RNA polymerase (strain K-l 2 
RFS 524 from R. F. Schleif) and bacteriophage T7 
North-Holland Publishing Company - Amsterdam 
RNA polymerase (rifampicin resistant) were generous 
gifts from R. Burgess and M. Chamberlin respectively. 
T7 bacteriophage was grown as described in ref. [lo] 
and purified on CsCl gradients. T7 DNA was extracted 
with phenol. Rifampicin was purchased from Ciba- 
Geigy A.G., Basel. 
The reaction mixture for RNA synthesis by E. coli 
rifampicin resistant RNA polymerase contained 
10 mM Tris-HCl pH 7.9, 50 mM NaCl, 10 mM 
MgClz ,0.2 mM dithiothreitol, 0.1 mM EDTA, 
100 pg/ml rifampicin, 60- 100 pg/ml T7 DNA and 
various amounts of wild type RNA polymerase. The 
same reaction mixture containing 20 mM MgCl? and 
1 mg/ml bovine serum albumin was used for RNA 
synthesis by bacteriophage T7 RNA polymerase. 
Rifampicin resistant RNA synthesis was started by 
simultaneous addition of either E. coli or bacterio- 
phage T7 rifampicin resistant RNA polymerase and 
the four nucleoside triphosphates to a reaction 
mixture containing T7 DNA complexed with various 
amounts of rifampicin-inactivated E. coli wild type 
RNA polymerase. 
3. Results 
In a first experiment, E. coli wild type RNA 
polymerase was inactivated with rifampicin. Com- 
plexes were formed between varying amounts of the 
inactivated enzyme and a constant amount of T7 
DNA. RNA synthesis was started by simultaneously 
adding to these solutions the four nucleoside tri- 
phosphates and a constant amount of either E. coli 
rifampicin resistant RNA polymerase or bacteriophage 
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T7 RNA polymerase. RNA synthesis was stopped 
after 2 min at 37°C. As shown in fig. 1, rifampicin- 
inactivated E. coli RNA polymerase inhibits efficiently 
RNA synthesis by E. coli rifampicin resistant enzyme, 
whereas it affects only slightly total RNA synthesis 
by bacteriophage T7 RNA polymerase. It is impor- 
pg 3 wild type RNA polymerose 
Fig. 1. Inhibition of RNA synthesis by rifampicin-inactivated 
RNA polymerase. 0 to 5.4 pg wild type E. coli RNA 
polymerase (about 80% active) were incubated 12 min at 
0°C in the buffer described in Materials and methods in the 
presence of rifampicin. 13 pg T7 DNA were added and the 
incubation was continued for 10 min at 37°C. The four 
nucleoside triphosphates, containing [14C]ATP at 4200 cpm/ 
nmol, were added to a final concentration of 200 PM each. 
In one series of assays 1 .O pug E. coli rifampicin-resistant RNA 
polymerase was added with the nucleoside triphosphates and 
the incubation was continued for 2 min 15 set at 37°C in a 
final volume of 230 ~1. In a series of blanks E. coli rifampicin 
resistant RNA polymerase was omitted. In the other series 
of assays 0.55 c(g T7 RNA polymerase was added and the 
reaction was continued for 1 min 45 set at 37°C in a final 
volume of 135 ~1. Here again in a series of blanks T7 RNA 
polymerase was omitted. The reactions were stopped by 
addition of 500 nmol ATP and 250 pg bovine serum albumin 
followed by 5% trichloroacetic acid. The acid insoluble 
[ 14C] AMP was determined. After subtraction of the blank 
values (constant over the whole range of concentration of 
wild type RNA polymerase) the RNA synthesis obtained 
in the absence of inactivated wild type RNA polymerase 
was taken as 100% and the other amounts were expressed as 
a percent of this value. The E. coli rifampicin resistant RNA 
polymerase and the bacteriophage T7 RNA polymerasc 
incorporated respectively 0.13 nmol and 0.28 nmol AMP 
into RNA in the absence of E. coli wild type RNA polymer- 
ase. The blank value was equivalent to 0.02 nmol ATP. RNA 
synthesis by E. coli rifampicin resistant RNA polymerase: 
---.---; RNA synthesis by bacteriophage T7 RNA 
polymerase: -A-. 
tant to note that in this experiment and in the fol- 
lowing one RNA synthesis was not limited by the 
amount of DNA present in the reaction mixture. 
Control experiments showed that with the highest 
amount of wild type RNA polymerase used in these 
experiments the RNA synthesis was, in absence of 
rifampicin, proportional to the amount of enzyme 
present in the reaction mixture. 
In a second experiment, E. coli wild type RNA 
polymerase was allowed to form complexes with T7 
DNA in the presence of rifampicin. As above, RNA 
synthesis was started by the simultaneous addition of 
the four nucleoside triphosphates and E. coli rifam- 
picin resistant RNA polymerase. After 16 min at 37”C, 
the reaction was stopped and the RNA synthesized 
was analyzed by polyacrylamide gel electrophoresis. 
The electrophoresis resolved the major specific RNA 
transcript made in vitro on T7 DNA by E. coli RNA 
polymerase holoenzyme (see fig. 2). This RNA has a 
molecular weight of about 2.2 X lo6 daltons [l l] 
and is transcribed from the DNA sequences expressed 
in vivo early after the bacteriophage infection [ 12,131. 
The relative amount of the 2.2 X 1 O6 dRNA was 
determined in each sample by scanning the auto- 
radiogram with a microdensitometer, and is also 
shown in fig. 2. These data show that the synthesis 
of the 2.2 X lo6 dT7 early RNA catalysed by E. coli 
rifampicin resistant RNA polymzrase is completely 
inhibited in vitro by rifampicin-inactivated wild type 
RNA polymerase. In a separate experiment I have 
shown with T7 RNA pre-synthesized in vitro that, in 
the conditions of the experiment shown in fig. 2, the 
inhibition of synthesis of the 2.2 X IO6 dRNA was not 
due to ribonuclease contamination of the wild type 
RNA polymerase preparation. 
4. Discussion 
The experiments I have presented show that 
specific RNA synthesis catalysed in vitro by E. coli 
rifampicin resistant RNA polymerase on a non- 
limiting amount of T7 DNA is inhibited by rifampicin- 
inactivated wild type RNA polymerase. 
The mechanism of this inhibition may be discussed 
in the light of two observations. The first is that 
rifampicin-inactivated E. coli RNA polymerase keeps 
its specificity of interaction with T7 DNA. Inactivated 
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Fig. 2. Inhibition of the in vitro T7 early RNA synthesis. In the five sample O-8 ccg wild type E. COJ~ RNA polymerase (about 
20% active) were mixed with rifampicin and 13 wg T7 DNA in the reaction mixture described in Materials and methods. Rifampicin 
was omitted in sample 1. After 6 min at 37”C, 2.5 rg E. coli rifampicin resistant RNA polymerase was added together with ATP, 
GTP and UTP at a final concentration of 400 pM each and a-labelled 32P CTP (97 cpm/pmol) at a final concentration of 200 PM 
in a final volume of 125 ~1. Rifampicin resistant RNA polymerase was omitted in sample 1. The incubation was continued for 
16 min at 37°C and terminated by addition of EDTA and SDS. 100 rl of each sample was electrophoresed on a 2% polyacryl- 
amide gel for 18 hr as described in ref. [20]. The autoradiogram was exposed 18 hr. The arrow indicates the 2.2 X lo6 dT7 early 
RNA synthesized in vitro. The relative amount of this RNA was determined by scanning the autoradiogram with a micro- 
densitometer. 
enzyme recognizes and binds to the same early 
promotor sites as it does in the absence of rifampicin 
[2]. Secondly, the rate of dissociation of an RNA 
polymerase-DNA complex is not afffected by inacti- 
vation of the enzyme with rifampicin [3]. The half- 
life of an RNA polymerase-promotor complex is about 
60 hr for T7 DNA in the conditions used in these 
experiments [ 11, a time very long compared with the 
times of incubation. Thus incubation of DNA with 
rifampicin-inactivated RNA polymerase or inactiva- 
tion of DNA-bound enzyme should result in the for- 
mation of a tight binding complex of rifampicin, 
enzyme and DNA located in the early promotor 
region of the chromosome. As rifampicin-inactivated 
enzyme is not able to initiate RNA synthesis in the 
presence of nucleoside triphosphates, it should block 
access to the early promoter binding sites. For lack 
of an accessible binding site in the early promoter 
region rifampicin resistant RNA polymerase would 
be unable to initiate specific RNA synthesis [ 1,141. 
RNA synthesis by bacteriophage T7 RNA polymer- 
ase is only slightly inhibited by rifampicin-inactivated 
E. coli RNA polymerase. On the basis of the mecha- 
nism described above this result is to be expected since 
E. coli RNA polymerase and bacteriophage T7 RNA 
polymerase use different promoters to initiate RNA 
synthesis in vitro on T7 RNA [ 151. 
The mechanism presented does not exclude this 
possibility that rifampicin-inactivated RNA polymerase 
inhibits elongation of RNA chains. A ternary trans- 
cription complex of RNA polymerase and RNA on 
DNA could conceivably be unable to displace a 
rifampicin-inactivated RNA polymerase molecule 
from a tight binding site on the same DNA molecule. 
It has indeed been shown that there are three or four 
strong binding sites [2] and three sites of RNA 
synthesis initiation [ 16,171 in the early promotor 
region of the T7 chromosome. 
Rifampicin-inactivated RNA polymerase has also 
been shown to inhibit the synthesis in vitro of 
rifampicin resistant RNA on bacteriophage T2 DNA 
[4,5,18]. This inhibition has, however, only been 
observed at a high enzyme to DNA ratio such that 
DNA was present at limiting concentration in the 
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reaction. The inhibition in this case may have been 
due rather to an inability of the rifampicin resistant 
RNA polymerase to elongate efficiently the nascent 
RNA chains than to an inability to initiate RNA 
synthesis [ 181. 
Bacteria heterozygous for the rifampicin alleles 
(rif-sensitive/rif-resistant) are generally sensitive to 
rifampicin [4-71 although about half the RNA 
polymerase molecules in such cells are known to 
be resistant in vitro to the antibiotic [4-61. Austin 
and Khesin and their collaborators have proposed 
that phenotypic dominance of sensitivity to rifam- 
picin is due to blocking of the DNA template [6] or, 
more specifically, to blocking of promoters [4,5], by 
rifampicin-inactivated rifampicin sensitive RNA 
polymerase. The data presented above support the 
hypothesis that initiation of RNA synthesis at certain 
promoters could be inhibited in heterodiploid cells 
by rifampicin-inactivated RNA polymerase molecules. 
It is, however, likely that the synthesis of RNA 
initiated at promoters with weak RNA polymerase 
binding sites would not be efficiently blocked by the 
inactivated enzyme. The slowness of inhibition of 
cell growth [6] and of RNA synthesis [ 191, after 
addition of rifampicin to rif-s/rif-r bacteria, the dif- 
ferential inhibition of protein synthesis [ 191 and the 
relative resistance of bacteriophage T2 development 
[5] show that gross RNA synthesis is not efficiently 
blocked in vivo by this mechanism. The known 
rifampicin sensitivity of rif-s/rif-r cells could be due 
to blockade of only a few genes which have strong 
promoter binding sites and whose expression is 
essential for growth. 
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